IFITM1 and neoplasm: Notably, the BAG2 overexpression group demonstrated a marked increase in interferon‐stimulated genes (ISGs), such as ISG15, MX1, IFITM1, OASL, and OAS1 (Figure 6B), which are known to facilitate CD8+ T cell recruitment to tumor sites.[31] This finding aligns with the role of interferon signaling in immune cell recruitment and the enhancement of anti‐tumor responses.[32] These results suggest that BAG2 may modulate STING‐mediated type I interferon responses.